The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review
Current Molecular Pharmacology · 2026 · 19 (1) · 27-40
DOI: 10.1016/j.cmp.2026.03.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Jiaoyu Yi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Lingjun Program, National Natural Science Foundation of China, China Academy of Space Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Shanghai Lingjun Program
- National Natural Science Foundation of China
- China Academy of Space Technology
Zitieren
APA
Yi, J., Tao, B., Chen, H., Horita, N., & Xu, Y. (2026). The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review. Current Molecular Pharmacology, 19(1), 27-40. https://doi.org/10.1016/j.cmp.2026.03.004
Vancouver
Yi J, Tao B, Chen H, Horita N, Xu Y. The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review. Current Molecular Pharmacology. 2026;19(1):27-40. doi:10.1016/j.cmp.2026.03.004
BibTeX
@article{Yi2026,
author = {Yi, Jiaoyu and Tao, Bo and Chen, Hao and Horita, Nobuyuki and Xu, Yong},
title = {The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {27--40},
doi = {10.1016/j.cmp.2026.03.004}
}
EUVIMED